Items

Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia and Herzegovina (2010-02)

V. Marković Peković, S. Stoisavljević-Šatara, R. Škrbić, Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia and Herzegovina, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, Vol. 66, No. 2, pp. 177 - 186, Feb, 2010
Outpatient Utilization of Antibiotics in the Republic of Srpska, Bosnia and Herzegovina, in 2007 and 2008 (2010-05)

V. Marković Peković, S. Stoisavljević-Šatara, Outpatient Utilization of Antibiotics in the Republic of Srpska, Bosnia and Herzegovina, in 2007 and 2008, SCRIPTA MEDICA, Vol. 41, No. 1, pp. 22 - 28, May, 2010
Banjalučke javne apoteke u austrougarskom periodu (2011-12)

V. Marković Peković, Banjalučke javne apoteke u austrougarskom periodu, GLASNIK UDRUŽENjA ARHIVSKIH RADNIKA, Vol. 3, No. 3, pp. 137 - 148, Dec, 2011
Essential to increase the use of generics in Europe to maintain comprehensive health care? (2012-01)

B. Godman, M. Bennie, C. Baumgartel, L. Sović-Brkičić, T. Burkhardt, J. Furst, K. Garuoliene, M. Gomes, V. Marković Peković, A. Martin, C. Sermet, P. Skiold, M. van Woerkom, L. Vončina, L. Gustafsson, Essential to increase the use of generics in Europe to maintain comprehensive health care?, STED Journal, Vol. 13, No. 3S, pp. 5 - 20, Jan, 2012
Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions (2012-09)

V. Marković Peković, R. Škrbić, B. Godman, L. Gustafsson, Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions, Expert Review of Pharmacoeconomics & Outcomes Research , Vol. 12, No. 5, pp. 661 - 671, Sep, 2012
Self-medication with antibiotics in the Republic of Srpska community pharmacies: pharmacy staff behavior (2012-10)

V. Marković Peković, N. Grubiša, Self-medication with antibiotics in the Republic of Srpska community pharmacies: pharmacy staff behavior, PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 21, No. 10, pp. 1130 - 1133, Oct, 2012
Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs (2013-05)

R. Malmstrom, E. Digene, C. Baumgartel, M. Bennie, I. Bishop, A. Brzezinska, S. Campbell, A. Ferrario, A. Finlayson, J. Furst, K. Garuoliene, M. Gomes, I. Gutierrez-Ibarluzea, A. Haycox, K. Hviding, H. Herholz, M. Hoffman, S. Jan, J. Jones, R. Joppi, M. Kalaba, C. Kvalheim, O. Laius, I. Langner, J. Lonsdale, S. Loov, K. Malinowska, L. McCullagh, K. Paterson, V. Marković Peković, A. Martin, J. Piessnegger, G. Selke, C. Sermet, S. Simoens, C. Tulnay, D. Tomek, L. Vončina, V. Vlahović-Palčevski, J. Wale, M. Wilcock, M. Wladysiuk, M. van Woerkom, C. Zara, L. Gustafsson, Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs, Frontiers in Pharmacology, Vol. 4, pp. 1 - 31, May, 2013
Outpatient utilization of systemic antibiotics in the Republic of Srpska (2013-05)

V. Marković Peković, S. Stoisavljević-Šatara, R. Škrbić, Outpatient utilization of systemic antibiotics in the Republic of Srpska, SCRIPTA MEDICA, Vol. 44, No. 1, pp. 8 - 13, May, 2013
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs (2014-06)

B. Godman, R. Malmstrom, E. Digene, S. Jayathissa, S. McTaggart, T. Cars, S. Alvarez-Madrazo, C. Baumgartel, A. Brzezinska, A. Bucsics, S. Campbell, I. Eriksson, A. Finlayson, J. Furst, K. Garuoliene, I. Gutierrez-Ibarluzea, K. Hviding, H. Herholz, R. Joppi, R. Joppi, M. Kalaba, O. Laius, K. Malinowska, H. Pedersen, V. Marković Peković, J. Piessnegger, G. Selke, C. Sermet, S. Spillane, D. Tomek, L. Vončina, V. Vlahović-Palčevski, J. Wale, M. Wladysiuk, M. van Woerkom, C. Zara, L. Gustafsson, Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs, Frontiers in Pharmacology, Vol. 5, pp. 1 - 11, Jun, 2014
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications (2014-06)

B. Godman, B. Wettermark, M. van Woerkom, J. Fraeyman, S. Alvarez-Madrazo, C. Berg, I. Bishop, A. Bucsics, S. Campbell, A. Finlayson, J. Furst, K. Garuoliene, H. Herholz, M. Kalaba, O. Laius, J. Piessnegger, C. Sermet, U. Schwabe, V. Vlahović-Palčevski, V. Marković Peković, L. Vončina, K. Malinowska, C. Zara, L. Gustafsson, Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications, Frontiers in Pharmacology, Vol. 5, pp. 1 - 9, Jun, 2014
Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future (2015-05)

B. Godman, M. Wilcock, A. Martin, S. Bryson, C. Baumgartel, T. Bochenek, W. de Bruyn, L. Sović-Brkičić, M. D'Agata, A. Fogele, A. Coma Fuste, J. Fraeyman, J. Furst, K. Garuoliene, H. Herholz, M. Hoffman, S. Jayathissa, H. Kwon, I. Langner, M. Kalaba, E. Magnusson, E. Anderse Karlssen, O. Laius, V. Marković Peković, E. Magnusson, S. McTaggart, H. Pedersen, J. Piessnegger, A. Ringerud, G. Selke, C. Sermet, K. Schiffers, P. Skiold, D. Tomek, A. Viksna, A. Vitry, C. Zara, R. Malmstrom, Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future, Generics and Biosimilars Initiative Journal, Vol. 4, No. 3, pp. 125 - 135, May, 2015
Outpatient antibiotic consumption in the Republic of Srpska during the period from 2009 to 2014 (2016-04)

L. Bojanić, M. Đermanović, J. Bojanić, J. Aćimović, V. Marković Peković, Outpatient antibiotic consumption in the Republic of Srpska during the period from 2009 to 2014, SCRIPTA MEDICA, Vol. 47, No. 1, pp. 47 - 52, Apr, 2016
Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina (2016-05)

V. Marković Peković, R. Škrbić, Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina, VOJNOSANITETSKI PREGLED, Vol. 73, No. 5, pp. 435 - 441, May, 2016
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future (2016-07)

W. de Bruyn, C. Ibanez, H. Pedersen, A. Akan, P. Vella Bonanno, L. Sović-Brkičić, A. Bucsics, G. Dedet, J. Eriksen, J. Fadare, J. Furst, G. Gallego, I. Godoi, A. Guerra Junior, H. Gursoz, S. Jan, J. Jones, R. Joppi, S. Kerman, O. Laius, N. Madzikwa, E. Magnusson, M. Maticic, V. Marković Peković, A. Massele, O. Ogunleye, A. O'Leary, J. Piessnegger, C. Sermet, S. Simoens, C. Tiroyakgosi, I. Truter, M. Thyberg, K. Tomek, M. Wladysiuk, S. Vandoros, E. Vural, C. Zara, Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future, Frontiers in Pharmacology, Vol. 7, pp. 1 - 18, Jul, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways (2016-09)

M. Ermisch, A. Bucsics, P. Vella Bonanno, F. Arickx, A. Bybau, T. Bochenek, M. van der Casteele, E. Digene, J. Furst, K. Garuoliene, M. van der Graff, J. Gulbinovic, A. Haycox, J. Jones, R. Joppi, O. Laius, I. Langner, A. Martin, V. Marković Peković, L. McCullagh, E. Magnusson, E. Nilsen, G. Selke, C. Sermet, S. Simoens, R. Sauremann, A. Schuurman, R. Ramos, V. Vlahović-Palčevski, C. Zara, B. Godman, Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways, Frontiers in Pharmacology, Vol. 7, pp. 1 - 9, Sep, 2016
Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future (2016-10)

V. Marković Peković, R. Škrbić, A. Petrović, V. Vlahović-Palčevski, J. Mrak, M. Bennie, J. Fadare, H. Kwon, K. Schiffers, I. Truter, B. Godman, Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future, Expert Review of Pharmacoeconomics & Outcomes Research , Vol. 16, No. 5, pp. 609 - 618, Oct, 2016
Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications (2017-06)

V. Marković Peković, N. Grubiša, J. Burger, L. Bojanić, B. Godman, Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications, Journal of Research in Pharmacy Practice, Vol. 6, pp. 120 - 125, Jun, 2017
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications (2017-08)

A. Ferrario, D. Araja, T. Bochenek, T. Ćatić, D. Danko, M. Dimitrova, J. Furst, I. Greičiute-Kuprijanov, I. Hoxha, A. Jakupi, E. Laidmae, O. Loblova, I. Mardare, V. Marković Peković, D. Meshkov, T. Novakovic, G. Petrova, M. Pomorski, D. Tomek, L. Vončina, A. Haycox, P. Kanavos, P. Vella Bonanno, B. Godman, The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications, PHARMACOECONOMICS, pp. 1 - 15, Aug, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation (2017-08)

P. Vella Bonanno, M. Ermisch, B. Godman, A. Martin, J. Van Den Bergh, L. Bezmelnitsyna, A. Bucsics, F. Arickx, A. Bybau, T. Bochenek, M. van der Casteele, E. Diogene, I. Eriksson, J. Furst, M. Gad, I. Greičiute-Kuprijanov, M. van der Graff, J. Gulbinovic, J. Jones, R. Joppi, M. Kalaba, O. Laius, I. Langner, I. Mardare, V. Marković Peković, E. Magnusson, O. Melien, D. Meshkov, G. Petrova, G. Selke, C. Sermet, S. Simoens, A. Schuurman, R. Ramos, J. Rodrigues, C. Zara, E. Zebedin-Brandl, A. Haycox, Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation, Frontiers in Pharmacology, Vol. 8, pp. 1 - 13, Aug, 2017
Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018-01)

T. Bochenek, V. Abilova, A. Alkan, B. Asanin, I. Beriain, Z. Besovic, P. Vella Bonanno, A. Bucsics, M. Davidescu, E. de Weerdt, N. Duborija-Kovacevic, J. Furst, M. Gaga, E. Gailite, J. Gulbinovic, E. Gurpinar, B. Hanko, V. Hargaden, T. Hotvedt, I. Hoxha, I. Huys, A. Inotai, A. Jakupi, H. Jenzer, R. Joppi, O. Laius, M. Lenormand, D. Makridaki, A. Malaj, K. Margus, V. Marković Peković, N. Miljkovic, J. de Miranda, S. Primozic, D. Rajinac, D. schwartz, R. Sebesta, S. Simoens, J. Slaby, L. Sović-Brkičić, T. Tesar, L. Tzirnis, E. Warminska, B. Godman, Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries, Frontiers in Pharmacology, Vol. 8, No. article 942, pp. 1 - 23, Jan, 2018

Items

Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia and Herzegovina (2010-02)

Outpatient Utilization of Antibiotics in the Republic of Srpska, Bosnia and Herzegovina, in 2007 and 2008 (2010-05)

Banjalučke javne apoteke u austrougarskom periodu (2011-12)

Essential to increase the use of generics in Europe to maintain comprehensive health care? (2012-01)

Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions (2012-09)

Self-medication with antibiotics in the Republic of Srpska community pharmacies: pharmacy staff behavior (2012-10)

Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs (2013-05)

Outpatient utilization of systemic antibiotics in the Republic of Srpska (2013-05)

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs (2014-06)

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications (2014-06)

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future (2015-05)

Outpatient antibiotic consumption in the Republic of Srpska during the period from 2009 to 2014 (2016-04)

Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina (2016-05)

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future (2016-07)

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways (2016-09)

Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future (2016-10)

Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications (2017-06)

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications (2017-08)

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation (2017-08)

Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018-01)